HHS will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials ...

Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month.

From rural New Hampshire to Galveston, fallout from President Trump’s battle with Harvard University extends far beyond ...

The Affordable Care Act survived yet another trip to the Supreme Court. The justices quibbled over just how powerful the ...

Researchers found that people living in non-industrialized societies experience less age-related chronic inflammation.

The U.S. Supreme Court declined to review an appeals court ruling that struck down key parts of an Oklahoma law regulating pharmacy benefit managers.

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.

In the French city of Marseille, a university's ambitions to poach American scientists could mask broader tensions over ...

Senate GOP unveiled changes to health care policies in tax legislation in a bid to win over Republican holdouts and pass ...

RFK Jr.’s plan to circumvent established medical journals smacks more of retaliation than reform, write three former NEJM editors.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...